1 – 50 of 97
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?
(
- Contribution to journal › Scientific review
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
(
- Contribution to journal › Article
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
2024) p.187-187(
- Contribution to conference › Abstract
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
- 2023
-
Mark
Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis
(
- Contribution to journal › Article
-
Mark
Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study
(
- Contribution to journal › Article
-
Mark
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis : a prospective study
(
- Contribution to journal › Article
-
Mark
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides
(
- Contribution to journal › Article
-
Mark
Data quality and patient characteristics in European ANCA-associated vasculitis registries : data retrieval by federated querying
(
- Contribution to journal › Article
-
Mark
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis : A Multinational Retrospective Study
(
- Contribution to journal › Article
-
Mark
High risk of stroke in ANCA-Associated vasculitis-a population-based study
(
- Contribution to journal › Article
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
(
- Contribution to journal › Article
-
Mark
Overcoming challenges in rare disease registry integration using the semantic web - a clinical research perspective
(
- Contribution to journal › Letter
- 2022
-
Mark
An update on polymyalgia rheumatica
(
- Contribution to journal › Scientific review
-
Mark
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
(
- Contribution to journal › Article
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
(
- Contribution to journal › Article
-
Mark
Clustering of anti-neutrophil cytoplasmic antibody-associated vasculitis - using a pre-processed harmonised dataset
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
An update on the epidemiology of Behçet’s disease in southern Sweden
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Myocardial infarction in ANCA-associated vasculitis- a population-based cohort-study
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Epidemiology and Clinical Characteristics of Adult-Onset IgA Vasculitis in Southern Sweden
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
-
Mark
Severe infections in patients with ANCA-associated vasculitis treated with rituximab
(
- Contribution to journal › Article
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
(
- Contribution to journal › Article
-
Mark
Global epidemiology of vasculitis
(
- Contribution to journal › Scientific review
-
Mark
The Role of Sural Nerve Biopsy in the Diagnosis of Vasculitis
(
- Contribution to journal › Article
-
Mark
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
(
- Contribution to journal › Article
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review
-
Mark
Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
(
- Contribution to journal › Article
-
Mark
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
(
- Contribution to journal › Article
- 2021
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
-
Mark
Comment on : Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply
(
- Contribution to journal › Letter
-
Mark
Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study
(
- Contribution to journal › Article
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
High risk of coronary artery aneurysm in Kawasaki disease
(
- Contribution to journal › Article
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Venous thromboembolism in ANCA-associated vasculitis : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis : A multinational study
(
- Contribution to journal › Article
- 2020
-
Mark
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica : A systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
(
- Contribution to journal › Article
-
Mark
Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis : a population-based case-control study
(
- Contribution to journal › Article
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article